A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Bojang, Kalifa ^a   Akor, Francis ^a   Bittaye, Ousman ^a   Conway, David ^a   Bottomley, Christian ^b   Milligan, Paul ^b   Greenwood, Brian ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; DIHYDROARTEMISININ; DUO COTECXIN; FANSIDAR; PIPERAQUINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; INCIDENCE; JAUNDICE; MAJOR CLINICAL STUDY; MALAISE; MALARIA; MORBIDITY; NAUSEA; OPEN STUDY; PRESCHOOL CHILD; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SLEEP DISORDER; VOMITING; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG TOXICITY; INFANT; PATIENT COMPLIANCE; SEASON;

ANTIMALARIALS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG TOXICITY; HUMANS; INFANT; MALARIA; PATIENT COMPLIANCE; SEASONS;

EID: 77955283844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011225     Document Type: Article

References (18)

1. WHO (2000) Experts Committee report on Malaria. Report. Geneva, WHO. pp 1-74.
2. Schellenberg D, Cissé B, Menendez C (2006) The IPTi Consortium: research for policy and action. Trends Parasitol 22: 296-300.
3. Cissé B, Sokhna C, Boulanger D, acqueline Milet, El Hadj Bâ, et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxinepyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, doubleblind trial. Lancet 367: 659-667.
4. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, et al. (2008) Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J 7: 123.
5. Sokhna C, Cissé B, Bâel H, Milligan P, Hallett R, et al. (2008) A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS ONE 3: e1471.
6. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, et al. (2008) Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS ONE 3: e4000.
7. Greenwood BM, Pickering H (1993) A review of the epidemiology and control of malaria in The Gambia, West Africa. Tran Roy Soc Trop Med Hyg 87 (suppl 2): 3-11.
8. Thomson MC, D'Alessandro U, Bennet S, et al. (1994) Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Tran Roy Soc Trop Med Hyg 88: 638-43.
9. Dunyo S, Ord R, Hallett R, Jawara M, Walraven G, et al. (2006) Randomised Trial of Chloroquine/Sulphadoxine-Pyrimethamine in Gambian Children with Malaria: Impact against Multidrug-Resistant P. falciparum. PLoS Clin Trials 1: e14.
10. Greenwood BM, Armstrong JRM (1991) Comparison of two simple methods for determining malaria parasite density. Tran Roy Soc Trop Med Hyg 85: 186-88.
11. Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348: 1196-201.
12. Phillips-Howard PA, W.L. (1990) Serious adverse drug reactions to pyrimethamine- sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J R Soc Med 83: 82-5.
13. Pussard E, Verdier F, Faurisson F, Scherrmann JM, Le Bras J, Blayo MC (1987) Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol 33: 409-414.
14. White NJ (2005) Intermittent presumptive treatment for malaria. PLoS Med 2: e3
15. Greenwood B (2007) Intermittent preventive antimalarial treatment in infants. Clin Infect Dis 45: 26-28.
16. Myint HY, Ashley EA, Day NP, Nosten F, White NJ (2007) Efficacy and safety of dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg 101: 858-866.
17. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, et al. (1996) Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. AmJ Trop Med Hyg 55(1 Suppl): 24-32.
18. Gosling R, Chandramohan D, Greenwood B. Drug options for intermittent preventive treatment for malaria in infants in an area with high resistance to sulfadoxine/pyrimethamine: an evaluation of short and long-acting antimalarial drugs, submitted.